A principal task in dissecting the genetics of complex traits is to identify causal genes for disease phenotypes. We previously developed a method to infer causal relationships among genes through the integration of DNA variation, gene transcription and phenotypic information. Here we have validated our method through the characterization of transgenic and knockout mouse models of genes predicted to be causal for abdominal obesity. Perturbation of eight out of the nine genes, with Gas7, Me1 and Gpx3 being newly confirmed, resulted in significant changes in obesity-related traits. Liver expression signatures revealed alterations in common metabolic pathways and networks contributing to abdominal obesity and overlapped with a macrophage-enriched metabolic network module that is highly associated with metabolic traits in mice and humans. Integration of gene expression in the design and analysis of traditional F 2 intercross studies allows high-confidence prediction of causal genes and identification of pathways and networks involved.
A principal task in dissecting the genetics of complex traits is to identify causal genes for disease phenotypes. We previously developed a method to infer causal relationships among genes through the integration of DNA variation, gene transcription and phenotypic information. Here we have validated our method through the characterization of transgenic and knockout mouse models of genes predicted to be causal for abdominal obesity. Perturbation of eight out of the nine genes, with Gas7, Me1 and Gpx3 being newly confirmed, resulted in significant changes in obesity-related traits. Liver expression signatures revealed alterations in common metabolic pathways and networks contributing to abdominal obesity and overlapped with a macrophage-enriched metabolic network module that is highly associated with metabolic traits in mice and humans. Integration of gene expression in the design and analysis of traditional F 2 intercross studies allows high-confidence prediction of causal genes and identification of pathways and networks involved.
The discovery of genes that contribute to complex human disorders remains a challenge for geneticists. The conventional method of determining whether a particular locus is involved in a given disease involves testing for inheritance of specific genomic regions in successive generations of individuals. This typically identifies loci (known as quantitative trait loci, or QTLs) each of which contributes modestly to the overall phenotype. Each locus may contain hundreds of genes, making the elucidation of the underlying gene or genes labor intensive and time consuming. Additionally, differentiating genes that are causal for the disease from those that are reactive to the biological alterations resulting from the disease has been difficult.
The advent of microarray technology has enabled scientists to simultaneously examine alterations in the abundance of thousands of transcripts in a sample. Because microarrays yield quantitative estimates of gene expression changes, the loci that control their expression can be mapped. These loci are known as expression QTLs (or eQTLs). eQTLs that map near the gene and are likely to regulate gene expression in cis are termed cis-eQTLs 1 . Genes with cis-eQTLs that coincide with a clinical disease-related trait QTL (or cQTL) have an increased likelihood of contributing causally to the particular disorder, especially if expression of the gene correlates with the severity of the disease trait 2, 3 .
However, correlation between an expression trait and a clinical phenotype does not necessarily imply a causal or reactive relationship because separate but linked genes may influence RNA levels and phenotypes independently, confounding the analysis. There is unambiguous biological directionality in that DNA changes influence alterations in transcript abundances and clinical phenotypes, so the number of possible relationships among correlated traits can be greatly reduced. For example, among two traits that are correlated and controlled by a unique DNA locus, only three likely relationship models exist: causal, reactive and independent 4, 5 . Therefore, after constructing a network, one can simultaneously integrate all possible DNA variants and their underlying changes in transcript abundance, and each relationship can be supported as being causal, reactive or independent in relation to a particular phenotype, such as obesity. This is referred to as the likelihood-based causality model selection (LCMS) procedure 4 .
Using the LCMS procedure, we had predicted B100 causal genes for abdominal obesity using an F 2 intercross between the C57BL/6J and DBA/2J strains of mice (the BXD cross) 4 . To validate the predictive power of LCMS, we characterized phenotypes of transgenic or knockout mouse models for nine of the top candidate genes and found eight out of the nine genes to influence obesity-related traits. We analyzed gene expression signatures in livers of the transgenic and knockout mice and demonstrated that all nine genes affect common pathways and subnetworks that relate to metabolic pathways, suggesting that obesity is driven by a gene network instead of a single gene.
RESULTS
Knockout or transgenic mouse models for the nine candidate causal genes were constructed or obtained from vendors or institutional investigators [6] [7] [8] (Supplementary Table 1 online). Except for GAS7, as noted below, transgene expression patterns were similar to those of the endogenous genes 4,7 ( Supplementary Fig. 1 online) . We previously validated ZFP90, C3ar1, Tgfbr2, LACTB and Lpl in modifying adiposity (ratio of total fat/body weight) in a preliminary analysis of knockout or transgenic mice 4,9 . Here we present further validation from these mouse models, and the obesity-related phenotypic characteristics, gene expression signatures, and pathway and network analyses of four more candidate causal genes: GAS7 (transgenic), GPX3 (transgenic), Gyk (knockout) and Me1 (knockout).
In vivo characterization of mouse models
We previously showed that ZFP90 tg mice had a significantly increased fat mass to lean mass ratio 4 . Further phenotyping indicated that ZFP90 tg mice also had significantly increased body weight, total fat pad mass, adiposity, and retroperitoneal, mesenteric and subcutaneous fat pad masses (Supplementary Table 2 online) compared to wild-type (WT) mice. Plasma lipid profiles showed nonsignificant trends for lowdensity lipoproteins and other parameters ( Supplementary Table 3 online), but our ability to assess these was limited because ZFP90 tg mice were unable to breed and we studied only three transgenic founders.
As described previously, male C3ar1 -/knockout and male Tgfbr2 +/heterozygous knockout mice (Tgfbr2 -/mice are not viable) had reduced fat/lean ratio as compared to their WT littermates 4 . Analysis of more mice of both sexes confirmed our previous results Table 2 ; Fig. 1a-d) . Notably, female C3ar1 knockout and female Tgfbr2 +/mice showed opposing trends ( Fig. 1b,d compared to Fig. 1a ,c). Individual fat pad masses were not significantly different between Tgfbr2 +/and WT, although males and females retained the opposite trends ( Supplementary Table 2 ). Similarly, male and female C3ar1 -/mice retained opposite trends in individual fat pad masses ( Supplementary Table 2 ), suggesting the existence of a sex-by-genotype interaction for C3ar1 and Tgfbr2. Female Tgfbr2 +/mice also showed a significant increase in endpoint free fatty acids (P = 0.02), but we saw no significant alterations in endpoint lipids for C3ar1 -/mice ( Supplementary Table 3 ).
(Supplementary
Heterozygous Lpl +/knockout mice were previously shown to have increased adiposity 9 . Male but not female heterozygotes also had significantly increased fat pad weights compared to controls (P r 0.03; Supplementary Table 2 ). Both male and female heterozygous mice had significantly increased endpoint triglycerides (P r 0.003). Females also showed increased unesterified and total cholesterol levels (P ¼ 0.02; Supplementary  Table 3 ).
The increased adiposity of LACTB tg mice noted previously 9 was confirmed in another LACTB tg line in female mice (P ¼ 2.7 Â 10 -7 ), but not in males ( Supplementary Fig. 2a ,b online). Neither male nor female transgenic mice showed alterations in individual fat pad weights or lipid levels ( Supplementary Tables 2 and 3) .
We constructed GAS7 tg mice as described in the Methods. The human transgene was found in all tissues analyzed except for the spleen, whereas the endogenous mouse Gas7 was only expressed noticeably in the brain ( Supplementary Fig. 1b ). Male but not female GAS7 tg mice showed significantly decreased fat/lean ratio as compared to WT littermates ( Fig. 1e,f ), which were confirmed in an additional independent GAS7 tg line ( Supplementary Fig. 2c,d) . Male GAS7 tg also had significantly decreased body weight, gonadal fat pad weight and total fat pad weight, and females had significantly decreased mesenteric fat pad weight (P r 0.03; Supplementary Table 2) . Moreover, male GAS7 tg showed significantly reduced triglycerides, unesterified cholesterol and glucose and significantly increased endpoint total cholesterol and high-density lipoproteins (HDL), whereas female transgenic mice showed only significantly reduced unesterified cholesterol (P r 0.05; Supplementary Table 3 ).
For GAS7 tg males, the difference in adiposity appeared at the first measurement time point at 11 weeks of age and the increase in the difference with age was not as obvious as in the other models. To assess a possible embryonic effect of the transgene, we measured body weights of male GAS7 mice at weaning (3 weeks) and found that these were not significantly different from littermate controls for both transgenic lines. The body weights at weaning from the GAS7 tg line analyzed in Figure 1e are presented as Supplementary Figure 2e .
GPX3 tg male but not female mice showed a significant decrease in fat/lean ratio growth compared to controls ( Fig. 1g,h ). No differences in individual fat pad weights were seen (Supplementary Table 2 ). Female GPX3 tg mice showed increased endpoint total cholesterol and HDL levels as compared to female controls (P r 0.02; Supplementary  Table 3 ).
Gyk is located on the X chromosome, and knockout males die by 4 d of age, whereas homozygous females probably die as embryos 8 . Therefore, only Gyk female heterozygous mice were characterized. There were no significant alterations in fat/lean ratio as compared to their WT littermates ( Supplementary Fig. 2f ), nor in individual or total fat pad weights (Supplementary Table 2 ). They did, however, show decreases in free fatty acids and glucose (P r 0.03; Supplementary Table 3 ).
The Me1 -/mice were characterized at a separate facility where the growth curves of body weight instead of adiposity were recorded while mice were on several different diets, including a medium high fat diet (44.9% kcal from fat) and a high sucrose diet (76.5% kcal from carbohydrate). Both male and female Me1 -/mice on a medium high fat diet showed decreased body weight ( Fig. 1i,j) . A similar trend was also observed in male (P = 4.6 Â 10 -13 ) though not female knockout mice on a high sucrose diet ( Supplementary Fig. 2g ,h). We measured adiposity by NMR at the beginning and the end of the diet period in the Me1 mice fed on high fat and high sucrose diets and did not find significant differences in initial or endpoint adiposity in mice on either diet ( Supplementary Fig. 2i ,j), though there was a trend toward reduced endpoint fat mass as determined by NMR in male knockout mice on high sucrose diet (7.61 ± 0.31 in knockout and 6.75 ± 0.26 in WT; P ¼ 0.06), consistent with the decreased body weight. Me1 -/mice on high fat but not a high sucrose diet showed a significant difference in food intake (males only) relative to littermate controls (P r 0.017; Supplementary Fig. 3 online) . Thus, food intake alone cannot account for the significantly decreased body weight in Me1 -/mice.
Gene expression profiling of mouse models
To explore the mechanisms underlying the observed phenotypic changes, we profiled male liver tissue from each mouse model (with the exception of the Gyk +/female) to obtain gene expression signatures for each of the individual candidate causal genes. At P o 0.05 (t-test), we observed hundreds to thousands of genes whose expression levels were altered in the livers of each of the transgenic or knockout mouse strains compared to their WT littermates ( Table 1 ). The false discovery rate (FDR) ranged from 1.9%-86% at this P-value cutoff. The high FDR values in most of the profiling experiments are likely to be due to the relatively small number of mice (n ¼ 3 to 9). The signature genes can be found in Supplementary Tables 4-12 online. We reasoned that although the relatively high FDR values would influence the confidence in individual signature genes identified, they should have less impact on the pathway analyses discussed below. Androgen and estrogen metabolism 5, 9 8 Figure 2 Disruption of metabolic pathways involved in fat pad mass in mouse models of the candidate genes. The nine mouse models are labeled 1 to 9 in red. Each of the metabolic pathways previously identified as different between fat and lean mouse is marked with the identifiers of the mouse models whose liver gene expression signatures are enriched for the specific pathway. The number of pathways that are over-represented in the liver gene expression signature of each mouse model is listed in parenthesis after the name of the mouse model. We used two complementary methods-Fisher's exact test-based enrichment analysis of Gene Ontology (GO) functional categories 10 , Panther pathways 11 or Ingenuity canonical pathways (Ingenuity Systems); and Gene Set Enrichment Analysis (GSEA) of curated functional gene sets from public databases based on weighted Kolmogorov-Smirnov-like statistics 12 -to analyze the functional relevance of the liver gene expression profiles to the phenotypic traits. The liver gene signatures from the mouse models were enriched for many overlapping metabolic pathways ( Table 1 ; Supplementary Table 13 online). Several mouse models showed enrichments for pathways related to steroid, fatty acid, amino acid and glutathione metabolism pathways, as well as purine metabolism, the pentose phosphate pathway and interleukin (IL)-10 signaling. Previously, we reported 13 tricarboxylic acid (TCA) cycle-centered metabolic pathways as being differentially affected in fat and lean mice from the F 2 DBA/J and C57BL/6J intercross 13 . Two or more over-represented metabolic pathways identified for each strain of mice in the current study overlapped with these previously described pathways (Fig. 2) . Therefore, the causal genes identified by the LCMS procedure and tested in this study are likely to affect adiposity by modifying similar obesity-related pathways. Moreover, the signature genes from each of the mouse models overlap significantly with the signature genes identified from one or more of the other mouse models ( Table 2) .
Overlap with a macrophage-enriched metabolic network On the basis of the coexpression networks constructed from liver and adipose tissues collected from a mouse cross between C57BL/6J (B6) and C3H/HeJ on an apolipoprotein E null background (BXH/apoE), we previously identified a macrophage-enriched metabolic network (MEMN) that is highly associated with metabolic traits and seems to be of macrophage origin 9 . Five of the nine genes under validationnamely, Zfp90, Lactb, Lpl, C3ar1 and Tgfbr2-were within this MEMN subnetwork. In addition, the liver gene signatures derived from five out of the nine validation mouse models-ZFP90 transgenic, GPX3 transgenic, Lpl knockout, C3ar1 knockout and Tgfbr2 knockout-significantly overlapped with MEMN genes ( Table 2) .
These candidate genes had been identified as causal genes for obesity from a C57BL/6 Â DBA/2J cross. Now, in a different mouse cross setting (BxH/apoE), many of these candidate genes and their downstream genes were confirmed to be within or highly overlap with a coexpression subnetwork that is relevant to obesity, diabetes and atherosclerosis traits. Furthermore, we recently uncovered a human MEMN that is associated with obesity-related traits and overlaps extensively with the mouse MEMN we describe here 14 . Therefore, it was not surprising to find C3AR1, LACTB and LPL as well as the previously characterized HSD11B1 (ref. 15 ) among the human MEMN network genes, further highlighting the networks shared between mice and humans and suggesting a common mechanism leading to the development of obesity.
Bayesian network analysis of liver signatures in mouse models
As the sample sizes for defining perturbation signatures were small, the quality of the signatures derived could be noisy, thus limiting our ability to see further significant overlaps between these signatures. To overcome the problem of noisy signatures, we projected them onto our liver transcriptional bayesian network and then compared the subnetworks around the signatures instead of signatures themselves 16 . 
Figure 3
A portion of the core subnetwork, derived from the liver transcriptional subnetworks representative of gene expression signatures of the mouse models of the candidate genes. The liver transcriptional network is the union of bayesian networks constructed from three crosses derived from B6, C3H and CAST. This core subnetwork consists of key regulators for fatty acid and lipid metabolism, including Insig1 and Insig2 (red), and is enriched for genes involved in related GO biological processes. A scalable image of the full subnetwork is included as Supplementary Figure 5 online.
We previously described a method to reconstruct probabilistic, causal bayesian networks by integrating genetic and gene expression data 4, 17 . A liver transcriptional network was constructed based on three F 2 intercross populations derived from the C57BL/6J, C3H/HeJ and CAST/Ei strains described previously 18 (see Methods). For each perturbation signature, we extracted the largest connected subnetwork in the whole liver transcriptional network as described 19 (see Methods). All of these subnetworks overlapped significantly with one another and with the MEMN module ( Table 3) , again suggesting that all causal genes affect a common pathway.
A core subnetwork consisting of 637 genes ( Fig. 3 ; Supplementary  Fig. 5 and Table 14 online) was common in at least five of the nine perturbation signature subnetworks, whereas there was no gene that was common in at least five of the nine perturbation signatures themselves. Genes in this core subnetwork were significantly enriched in many GO biological processes ( Table 4 ) and also significantly overlapped with the coexpression module MEMN described above. The core subnetwork consisted of Zfp90, Lactb, the well known, key regulators of fatty acid and lipid metabolism Insig1 and Insig2 (refs. 20,21) , and many classic cholesterol and fatty acid metabolic genes such as Hmgcs1, Sqle, Dhcr7 and Fasn. This suggests that the possible mechanism of the nine candidate causal genes giving rise to the obesity phenotype is perturbation of this core subnetwork.
Relationship to human genome-wide association findings
Recent genome-wide association studies (GWAS) have identified more than ten loci that are associated with obesity-related traits [22] [23] [24] [25] [26] [27] [28] . These loci include highly replicated ones such as FTO and MC4R as well as less replicated ones such as INSIG2, GNPDA2, TMEM18, NEGR1 and SH2B1. Although none of the nine causal genes that we have tested are within the obesity GWAS findings, the obesity GWAS gene INSIG2 is within the core subnetwork that we identified, and LPL has been associated with triglyceride and HDL traits in GWAS 29, 30 .
One way to link our study to human GWAS is to test whether the causal genes we identified in mouse are enriched for variations in human populations that show evidence of association (for example, low P-values that may not reach the stringent threshold required for genome-wide significance) with obesity traits. Using data from the Broad Institute GWAS control population 31 , we tested the 637 core subnetwork genes for enrichment of neighboring SNPs (termed cis-SNPs) with low body mass index (BMI) association P-values (see Methods for details). We did not find any enrichment for cis-SNPs with low association P-values to BMI among the genes composing the full core subnetwork set. However, when we considered the 102 mouse MEMN genes within the core subnetwork, we did observe a significant enrichment for SNPs with low association P-values to BMI.
Specifically, 12.5% (267 out of 2,132) of cis-SNPs selected from the 102 mouse MEMN genes in the core subnetwork reached an BMI association cutoff of P o 0.1, as compared to an average of 10.4% (95% confidence interval 7.9% to 12.6%) in the cis-SNPs derived from 10 5 sets of randomly selected 102 genes by permutation (Supplementary Fig. 4a online) . The enrichment P-value, defined as the probability of obtaining the observed result or one even more extreme under random sampling, was 0.031. In addition, the average log of association P-values (logP) for the cis-SNPs of the 102 mouse MEMN core subnetwork genes was -1.11, as compared to an average of -1.00 (95% confidence interval -1.10 to -0.91) in the 10 5 random sets (P ¼ 0.010; Supplementary Fig. 4b ).
DISCUSSION
Genetic perturbation of eight out of the nine candidate genes (or B90%) that were predicted to be causal for obesity in mice using our LCMS procedure caused significant alterations in fat/muscle ratios as well as relevant changes in body weight, adiposity, individual fat pad masses or plasma lipids (summarized in Table 5 ). Furthermore, we identified corresponding changes in the liver expression of genes involved in metabolic pathways previously identified to be differentially regulated between fat and lean mice 13 . Therefore, most of the candidate causal genes for abdominal obesity predicted by LCMS were validated at both a phenotypic and a gene expression level. The liver gene expression signature genes from the validation mouse models highly overlapped with one another and with the metabolic traitassociated MEMN module genes. All of these causal candidate genes affected a common liver transcriptional subnetwork that is enriched for GO metabolic pathways and the MEMN module. These many lines of evidence suggest that the perturbation of these predicted causal genes influences obesity through a common functional mechanism.
Sex specificity in phenotypic effect was common, and we observed opposing effects on abdominal obesity between the sexes in C3ar1 -/and Tgfbr2 +/mice. Sex hormones can affect Tgfbr2 expression 32 , and C3a stimulates the release of adrenocorticotropic hormone, which is involved in the production of androgens 33 . Downregulation of both genes in the knockout mouse models may alter the impact of sex hormones and lead to sex-specific phenotypes.
Among the newly validated genes, Gas7 was originally identified as a gene expressed in serum-starved NIH3T3 cells, and its protein structure resembles that of Oct2 and synapsins, which are involved in neuronal development and neurotransmitter release, respectively 34, 35 . It is selectively expressed in mature cerebral cortical, hippocampal and cerebellar neurons 35 . Our studies now indicate relevance of this gene to fat metabolism and other pathways not previously known to be connected with it, such as the insulin signaling pathway.
GPX3 is involved in cellular protection against oxidative damage through the reduction of peroxides 36 . The cytosolic isoform of GPX3, GPX1, has been associated with obesity 37 , and recently the dysregulation of GPX3 in the plasma and fat of obese subjects has been implicated in the increase in inflammatory signals and oxidative stress and hence obesity-related metabolic disorders 38 . Our study provides primary evidence that Gpx3 is causal for obesity and supports the idea that Gpx3 overexpression modifies insulin resistance 38 . Although the Cofactor metabolic process 2.01 Â 10 -5 19 149
All P-values are derived from Fisher's exact test and pass Bonferroni corrected P o 0.05. The background for overlapping between gene sets and subnetworks in liver transcriptional network is 14,882 genes included in the whole network, and the core subnetwork size is 637 genes.
magnitude of the effect of GPX3 tg on phenotype was relatively weak (Fig. 1g,h) , the liver gene expression signature from the GPX3 mice highly overlaps the signatures of the GAS7 tg , LACTB tg , Gyk +/and Lpl +/mice as well as the MEMN genes ( Table 2 ), suggesting that Gpx3 is causally affecting abdominal obesity along with the other genes validated in our study. The weak phenotypic validation might be a result of low copy number of the transgene 7 and susceptibility to compensatory mechanisms in gene networks 9 . Me1 encodes a cytosolic NADP + -dependent enzyme involved in the regeneration of pyruvate from malate back to the mitochondria, forming a link between the glycolytic pathway and the citric acid cycle 39 . By assisting with the release of acetyl-coenzyme A (CoA) and NADPH from the mitochondria into the cytosol, it makes these compounds available for de novo fatty acid biosynthesis and other metabolic processes. Me1 is considered lipogenic, and altered Me1 enzyme activity has been associated with obesity in mouse and rat models 40, 41 . Recently, Me1 was identified as a primary candidate gene underlying a porcine QTL associated with back fat thickness 42 .
Gyk encodes an enzyme responsible for the metabolism of endogenous and dietary glycerolipids 8 . Deficiency in Gyk activity has been linked to altered fat and lipid metabolism 8, 43 , and Aqp7 deficiency, which elevates Gyk activity, has been associated with obesity development 44 . In this study, we did not validate this gene at the phenotypic level. However, pathway analysis of the liver Gyk +/signature indicated that 5 out of 13 of the metabolic pathways previously linked to fat content were affected, and the Gyk +/liver signature overlapped substantially with the signatures derived from mouse models of other validated genes, including Gas7, Gpx3, Lactb and Me1, supporting a causal role. The lack of phenotypic validation might be a result of insufficient perturbation represented by the heterozygous knockout.
When directly comparing our causal genes with the findings from the recent human GWAS studies, we only found limited overlaps. We reason that the GWAS loci represent the cis variations in human population that confer disease risk, whereas by requiring multiple overlapping loci between the expression and fat mass traits in our LCMS method we implicitly required the causal genes to be affected in trans by a given genetic locus and then cause variations in the obesity traits. Thus, it is not surprising to observe a limited overlap between the GWAS genes and the mouse causal genes we have identified. The causal genes that are affected by DNA variation in trans may not have been identified in the GWAS because the signals were too subtle to detect at the current scale, yet are still of interest because they are supported as causal. We found a weak enrichment for SNPs with low association P-values to BMI from the Broad Institute GWAS population 31 when the mouse MEMN genes within the core subnetwork were considered, which supports this hypothesis.
In summary, we have validated most of the top genes predicted to be causal for abdominal obesity through phenotypic characterization and gene expression profiling, thus supporting the LCMS as a powerful tool in predicting causal genes for diseases. Although the genes are seemingly disparate, each seems to affect metabolic pathways that are linked to the TCA cycle. Future directions include the application of these network approaches to other relevant tissues, such as fat, with incorporation of potential cross-tissue interactions, as well as environmental variations. Also, the investigation of negative predictive value of the LCMS procedure would be of value, though this is a more complicated problem than it seems on the surface, given that a list of LCMS-predicted causal genes from one tissue is by no means comprehensive as many tissues are involved in the regulation of body fat. Considering that many genes influence body weight, focusing on pathways and networks rather than pinpointing individual genes may be more efficient in elucidating the pathogenesis of obesity and developing of new treatments.
METHODS
Construction of mouse models. Details regarding the GAS7 transgenic and Me1 knockout mouse models can be found in the Supplementary Methods online. The ZFP90, LACTB and GPX3 transgenic and Gyk and Lpl knockout mouse models were constructed as described previously 4, [6] [7] [8] . Tgfbr2 and C3ar1 knockout mice were obtained from Deltagen as described previously 4 .
Breeding and genotyping of mice. All mice except Me1 mice were bred at UCLA and were fed a 4%-chow diet (Harlan Teklad 7017; 4% fat, 0% cholesterol) ad libitum and maintained on a 12 h light/dark cycle. Genomic DNA was isolated from ear and tail samples using a DNeasy kit (Qiagen) and genotyped using PCR. All reactions were carried out using initial enzyme activation at 95 1C for 5 min followed by 35 cycles at 95 1C for 30 s, 56 1C for 30 s and 72 1C for 1 min, and finished with an extension at 72 1C for 7 min. A detailed method for breeding and genotyping Me1 À/À mice has been described 41 . Phenotypic characterization of the mouse models. Starting at 11 weeks of age, mice (except Me1 -/-) were fed a 6%-chow diet (Harlan Teklad 7013; 6.25% fat, 0% cholesterol) for 12 weeks. Each mouse was monitored for body weight and evaluated by NMR (Brucker Minispec) for body weight composition including lean mass, fat mass and water content over the course of the diet every 2 weeks. At the end of the 12-week diet, we put mice to death using CO 2 asphyxiation. Gonadal (surrounding the gonads), retroperitoneal (beneath the kidneys), mesenteric (attached to the intestines) and subcutaneous (below the surface of the skin on the thighs) fat pads were collected and weighed. Liver was collected for RNA profiling. All procedures were done in accordance with the current US National Research Council Guide for the Care and Use of Laboratory Animals and were approved by the University of California Los Angeles Animal Research Committee. Further details regarding the characterization of the Gpx3 and Me1 mice can be found in the Supplementary Methods.
Analysis of phenotypic data. Student's t-test was used to analyze the differences in the phenotypic traits between transgenic or knockout mice and their WT littermate controls. The significance level was set to P o 0.05. Significance of the difference in the growth curves of fat/muscle ratio between transgenic or knockout and WT controls for all mouse models except Me1 -/mice and in growth curves of body weight for Me1 -/mice was determined using an autoregressive method described previously to enhance the power of difference detection by leveraging repeated measures, over several time points, for each mouse 4 .
RNA sample preparation and microarray processing. For the liver tissues from the ZFP90 transgenics, the Tgfbr2 +/-, the C3ar1 -/-, the Lpl +/-, the Me1 -/and each of their respective littermate control mice, RNA preparation and array hybridizations were performed at Rosetta Informatics. For C3ar1, Tgfbr2 and ZFP90 mouse strains, the custom ink-jet microarrays used in this study were manufactured by Agilent Technologies and consisted of 23,574 non-control oligonucleotides extracted from mouse Unigene clusters and combined with US National Center for Biotechnology Information Reference Sequence (RefSeq) sequences and RIKEN 45 Selection of active or expressed gene sets based on microarray profiling. As a limited number of mice (n ¼ 3-9) per mouse model was used for gene expression profiling and the statistical power was low considering the large number of multiple tests for tens of thousands genes, we restricted attention to the subsets of genes that are more biologically relevant. The Agilent arrays do not provide a measure of 'presence' or 'absence' , and therefore, we selected set of 'most transcriptionally active genes' for mouse models profiled with Agilent arrays using the program Resolver 3,46,47 . The active genes were defined as those with significance level P o 0.05 (as determined by error model 3, 46, 47 ) in at least 10% of the mice for each strain, including both transgenic or knockout and controls. These active genes represent those whose expression varies across samples and thus are more biologically relevant. For mouse strains that were profiled with Illumina arrays, the program BeadArray was used to normalize the expression intensity values across as well as within arrays using the ''average'' algorithm embedded in the software. Genes with detection scores of 40.99 (corresponding to detection P o 0.01) in at least 10% of the mice for each strain of mice were selected as 'expressed' genes. This active and expressed gene selection procedure substantially reduced the size of starting gene sets for subsequent analysis, from B24,000 to B1,000-9,000 genes per strain of mouse, thus helping to alleviate multiple-testing concerns.
Selection of signature gene sets based on microarray profiling. A Student's t-test was used to identify genes with significant differences between transgenic or knockout mice and the corresponding WT control mice. These genes were defined as ''signature'' genes, representing the perturbed gene expression signature as a result of single gene modification. The significance level was set to P o 0.05. The false discovery rate at this significance level was calculated using Q-value as reported 48 . All statistical analyses were carried out in the R statistical environment.
Pathway analysis. Each signature gene set identified above was classified using Gene Ontology (GO) 10 and Panther pathway 11 database assignments. The Ingenuity Pathway Analysis software (Ingenuity Systems, http://www.ingenuity. com) was used to analyze the enrichment of canonical pathways in the signature genes identified above, and we also analyzed the enrichment of B470 functional gene sets curated from public databases using GSEA 12 . More details can be found in the Supplementary Methods.
Mouse crosses and tissue collection. Three mouse crosses constructed from C57BL/6J (B6), C3H/HeJ (C3H) and CAST/Ei (CAST)-namely, B6 Â C3H wild-type (BXH/wt), B6 Â C3H on an ApoE null background (BXH/apoE) and B6 Â CAST (BXC)-were described previously 18, 49 . More details can be found in the Supplementary Methods.
Identification of the macrophage-enriched metabolic network. The construction of the coexpression network using liver and adipose tissues from BXH cross and the identification of the MEMN has been described previously 9 . Briefly, both genotype and gene expression data were used to construct coexpression networks that consisted of highly connected genes from each tissue and sex. An iterative search algorithm was then used to detect highly interconnected subnetworks. One particular subnetwork that was highly enriched for causal genes for all metabolic traits tested, highly conserved between tissues and sexes, and highly enriched for macrophage genes was referred to as MEMN.
Construction of bayesian network and subnetwork for candidate causal gene perturbation signatures. Liver expression data generated from the above three mouse cross populations BXH/WT, BXH/apoE and BXC was integrated with the genotypic data also generated in the same populations to reconstruct the bayesian networks as previously described [21] [22] [23] [24] . More details can be found in the Supplementary Methods. The construction of a subnetwork for a set of signature genes in the network is as follows: given a set of genes, we identified all of the nearest neighbors of these genes in the network (that is, we identified all nodes in the network that were either in the input set or directly connected to a node in the input set). This first step produced a set of node pairs connected by an edge. In the next step, direct connections (edges) among all the nodes in these pairs were identified and added. The resulting largest connected subnetwork (that is, after removal of all smaller subnetworks that disconnect from the largest connected subnetwork) was used as the subnetwork to represent the input set of signature genes.
The core subnetwork was identified by searching for genes that were present in more than half-in this case, five-of the subnetworks representing the nine liver signature gene sets of the mouse models. The enrichment of the core subnetwork for 2,283 gene sets from GO Biological Processes category was analyzed using Fisher's exact test. A statistical cutoff of 2.2 Â 10 -5 was applied to the nominal P-values to reflect the Bonferroni correction of multiple testing.
Comparison of signature genes across mouse models, between signature genes and the bayesian subnetwork, and between signature genes and MEMN genes. The significance of overlap between different gene sets was estimated using Fisher's exact test statistics under the null hypothesis that the frequency of the genes in one signature set was the same between a reference set of 18,739 genes with Entrez Gene identifier and the comparison gene set. The background for overlapping between gene sets and subnetworks in liver transcriptional network was 14,882 genes included in the whole network. Enrichment of core subnetwork for genes and loci with low association P-values to obesity traits in GWAS. The raw association P-values between SNPs and BMI from the GWAS conducted by the BROAD Institute 31 were downloaded from the official website (http://www.broad.mit.edu/diabetes/). For each gene in the 637 core subnetwork and the 102 mouse MEMN module 9 genes within the core subnetwork, SNPs within a 100 kb distance (50 kb upstream and 50 kb downstream), termed cis-SNPs, were selected from dbSNP database and their association P-values to BMI in the control population of the BROAD GWAS study were extracted. We compared each set of cis-SNPs of interest with 10 5 sets of cis-SNPs from randomly selected gene sets with matched size on the Rosetta/Merck Human 44k 1.1 microarray (GEO platform identifier GPL4372), such that the number of cis-SNPs from the random gene sets roughly matched that of the gene sets of our interest. Two different tests were used to estimate the significance of enrichment for low association P-values as detailed in Supplementary Methods.
